Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs6737490 | chr2:118601177 | T/C | 1.95E-5 | 176 | 25.4 | 25.97 | 11.65 | KM Plot |
PCPG | rs6738676 | chr2:24329344 | T/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs67397664 | chr2:24343867 | ACTTT/A | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs67413943 | chr14:74387982 | A/G | 1.22E-5 | 175 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs67448739 | chr2:241526862 | C/T | 4.48E-5 | 174 | 26.57 | 21.82 | 10.3 | KM Plot |
PCPG | rs6747185 | chr2:242544925 | A/G | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs67480523 | chr13:114155411 | G/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs6748257 | chr2:24329119 | G/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs675108 | chr13:37503645 | T/C | 0.000352 | 177 | 6.37 | 24.85 | 25.7 | KM Plot |
PCPG | rs6751180 | chr2:242510954 | A/C | 2.94E-5 | 170 | 25.87 | 25.6 | 20.28 | KM Plot |
PCPG | rs6751268 | chr2:242539731 | T/C | 2.55E-5 | 175 | 25.87 | 26.47 | 20.28 | KM Plot |
PCPG | rs6751542 | chr2:238829715 | G/C | 1.46E-5 | 170 | 23.03 | 34.37 | 2.93 | KM Plot |
PCPG | rs6752397 | chr2:118532055 | G/A | 1.54E-5 | 178 | 25 | 30.33 | 11.65 | KM Plot |
PCPG | rs6754085 | chr2:242510779 | T/C | 4.32E-5 | 170 | 25.87 | 25.47 | 20.28 | KM Plot |
PCPG | rs67540871 | chr16:71498013 | GATA/G | 0 | 177 | 24.52 | 29.02 | 3.17 | KM Plot |